As of Q4 2024, the wholesale acquisition cost (WAC) of cancer drug Herceptin was around 4,363 U.S. dollars, compared to 3,402 U.S. dollars for the biosimilar Trazimera. Biosimilars were able to reduce the cost between 10 and 22 percent. This statistic illustrates a comparison of the WAC of Herceptin vs biosimilars in the United States, as of Q4 2024.
Comparison of the wholesale acquisition cost (WAC) of Herceptin vs biosimilars in the United States as of Q4 2024
(in U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Samsung Bioepis. (October 10, 2024). Comparison of the wholesale acquisition cost (WAC) of Herceptin vs biosimilars in the United States as of Q4 2024 (in U.S. dollars) [Graph]. In Statista. Retrieved December 22, 2024, from https://www.statista.com/statistics/1186607/comparison-wac-herceptin-vs-biosimilars-us/
Samsung Bioepis. "Comparison of the wholesale acquisition cost (WAC) of Herceptin vs biosimilars in the United States as of Q4 2024 (in U.S. dollars)." Chart. October 10, 2024. Statista. Accessed December 22, 2024. https://www.statista.com/statistics/1186607/comparison-wac-herceptin-vs-biosimilars-us/
Samsung Bioepis. (2024). Comparison of the wholesale acquisition cost (WAC) of Herceptin vs biosimilars in the United States as of Q4 2024 (in U.S. dollars). Statista. Statista Inc.. Accessed: December 22, 2024. https://www.statista.com/statistics/1186607/comparison-wac-herceptin-vs-biosimilars-us/
Samsung Bioepis. "Comparison of The Wholesale Acquisition Cost (Wac) of Herceptin Vs Biosimilars in The United States as of Q4 2024 (in U.S. Dollars)." Statista, Statista Inc., 10 Oct 2024, https://www.statista.com/statistics/1186607/comparison-wac-herceptin-vs-biosimilars-us/
Samsung Bioepis, Comparison of the wholesale acquisition cost (WAC) of Herceptin vs biosimilars in the United States as of Q4 2024 (in U.S. dollars) Statista, https://www.statista.com/statistics/1186607/comparison-wac-herceptin-vs-biosimilars-us/ (last visited December 22, 2024)
Comparison of the wholesale acquisition cost (WAC) of Herceptin vs biosimilars in the United States as of Q4 2024 (in U.S. dollars) [Graph], Samsung Bioepis, October 10, 2024. [Online]. Available: https://www.statista.com/statistics/1186607/comparison-wac-herceptin-vs-biosimilars-us/
